(Q50467882)

14 March 2018

title

Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. (English)

1 reference

14 March 2018

sensorineural hearing loss

1 reference

1 reference

6

1 reference

14 March 2018

Suzanne L Wolden

9

object named as

Suzanne L Wolden

1 reference

14 March 2018

author name string

William C Chen

1

1 reference

14 March 2018

Andrew Jackson

2

1 reference

14 March 2018

Amy S Budnick

3

1 reference

14 March 2018

David G Pfister

4

1 reference

14 March 2018

Dennis H Kraus

5

1 reference

14 March 2018

Hilda Stambuk

7

1 reference

14 March 2018

Sabine Levegrun

8

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 February 2006

1 reference

14 March 2018

published in

Cancer

1 reference

14 March 2018

volume

106

1 reference

14 March 2018

issue

4

1 reference

14 March 2018

page(s)

820-829

1 reference

14 March 2018

Radiation-induced hearing impairment in patients treated for malignant parotid tumor.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Postirradiation sensorineural hearing loss: a common but ignored late radiation complication.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Late radiation effects on hearing, vestibular function, and taste in brain tumor patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Irradiation of the Ear

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

A comprehensive three-dimensional radiation treatment planning system.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

A gradient inverse planning algorithm with dose-volume constraints.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Ultrastructural and electrophysiologic changes of rat cochlea after irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Post-radiation sensorineuronal hearing loss.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Radiotherapy enhanced ototoxicity of cisplatin in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Early detection of cisplatin ototoxicity. Selected case reports.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Radiation dose to otologic structures during head and neck cancer radiation therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21683

7 January 2021

Identifiers

DOI

10.1002/CNCR.21683

1 reference

14 March 2018

1 reference

14 March 2018